The book "Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology" offers a comprehensive analysis of anemia, which frequently occurs in cancer patients and their treatment. In the second edition, the effects of anemia on quality of life, metabolic functions, and the lifespan of patients are discussed in detail. The authors, including leading international experts, present current scientific findings and clinical aspects of anemia in oncology. The work provides diagnostic and therapeutic recommendations for the use of rhEPO and highlights future developments in this field. It is aimed at professionals from various disciplines, including oncologists, hematologists, and transfusion medicine specialists, and is considered an essential source of information for the treatment of anemia in cancer patients.